Cargando…
Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development
Cancer is a leading cause of mortality worldwide and matters are only set to worsen as its incidence continues to rise. Traditional approaches to combat cancer include improved prevention, early diagnosis, optimized surgery, development of novel drugs, and honing regimens of existing anti-cancer dru...
Autores principales: | Stenvang, Jan, Kümler, Iben, Nygård, Sune Boris, Smith, David Hersi, Nielsen, Dorte, Brünner, Nils, Moreira, José M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872326/ https://www.ncbi.nlm.nih.gov/pubmed/24400218 http://dx.doi.org/10.3389/fonc.2013.00313 |
Ejemplares similares
-
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol
por: Kümler, Iben, et al.
Publicado: (2015) -
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
por: Kümler, Iben, et al.
Publicado: (2019) -
Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021) -
Prediction and Identification of GPCRs Targeting for Drug Repurposing in Osteosarcoma
por: Tan, Manli, et al.
Publicado: (2022)